You Are Here:
This topic is in the process of being updated. Please go to the Update in Progress section to see the latest documents available.
This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on low-dose aspirin for the prevention of morbidity and mortality from preeclampsia (formerly aspirin prophylaxis in pregnancy).
Release Date: 1996
Guide to Clinical Preventive Services, 2nd Edition
Aspirin Prophylaxis in Pregnancy
Update in Progress
In an effort to make the USPSTF recommendations clearer and its processes more transparent, the Task Force is sharing drafts of many of its documents for public comment, including draft Research Plans and draft Recommendation Statements. As a result, the final Recommendation Statement is not yet available.
The research team at the Evidence-based Practice Center independently gathers and reviews the available published evidence to address the questions posed by the USPSTF. The resulting draft Evidence Review is critiqued by national subject matter experts before being finalized.
|Evidence Review||Related Items|
|Evidence Summary (PDF File, 355 KB; PDF Help)||Final Evidence Review (PDF File, 1.3 MB; PDF Help)|
The USPSTF reviews the final Evidence Review, evaluates the benefits and harms of the clinical preventive service, and discusses and develops one or more preliminary specific recommendations. The resulting draft Recommendation Statement is posted on this Web site for public comment before being finalized.
|Recommendation Statement||Related Items|
|Draft Recommendation Statement for Public Comment
(April 8–May 5, 2014)
|Consumer Fact Sheet (PDF File, 69 KB; PDF Help)|
Current as of April 2014
Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia, Topic Page. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspsaspg.htm